StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$5.08+0.58 (+12.89%)

Close on Nov 19, 2026Market cap $395.96MP/E –Yield –

CorMedix shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

CorMedix's shares outstanding was 92M at Jun 30, 2026. For fiscal 2025 it was 0M, up 36.4% from the year before. Over ten years it grew -44.9% a year on average. The highest annual figure on record is 55M in fiscal 2017.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20250M+36.4%
FY2024Dec 31, 20240M-99.9%
FY2023Dec 31, 202351M+26.4%
FY2022Dec 31, 202240M+6.9%
FY2021Dec 31, 202138M+31.9%
FY2020Dec 31, 202029M+18.3%
FY2019Dec 31, 201924M+35.6%
FY2018Dec 31, 201818M-67.7%
FY2017Dec 31, 201755M+45.2%
FY2016Dec 31, 201638M+21.1%
FY2015Dec 31, 201531M+46.2%
FY2014Dec 31, 201421M+55.1%
FY2013Dec 31, 201314M+21.2%
FY2012Dec 31, 201211M0.0%
FY2011Dec 31, 201111M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202692M+34.1%
Q1 FY2026Mar 31, 202693M+58.1%
Q3 FY2025Sep 30, 202586M+49.6%
Q2 FY2025Jun 30, 202572M+25.1%
Q1 FY2025Mar 31, 202569M+20.0%
Q3 FY2024Sep 30, 202459M+4.0%
Q2 FY2024Jun 30, 202458M+27.0%
Q1 FY2024Mar 31, 202458M+30.4%
Q4 FY2023Dec 31, 202357M+37.2%
Q3 FY2023Sep 30, 202357M+37.3%
Q2 FY2023Jun 30, 202345M+14.1%
Q1 FY2023Mar 31, 202344M+15.3%
Q4 FY2022Dec 31, 202242M+9.8%
Q3 FY2022Sep 30, 202241M+8.1%
Q2 FY2022Jun 30, 202240M+4.4%
Q1 FY2022Mar 31, 202238M+5.3%
Q4 FY2021Dec 31, 202138M+17.6%
Q3 FY2021Sep 30, 202138M+28.8%
Q2 FY2021Jun 30, 202138M+45.7%
Q1 FY2021Mar 31, 202136M+39.4%
Q4 FY2020Dec 31, 202032M+26.2%
Q3 FY2020Sep 30, 202030M+23.3%
Q2 FY2020Jun 30, 202026M+9.7%
Q1 FY2020Mar 31, 202026M+12.9%
Q4 FY2019Dec 31, 201926M+22.7%
Q3 FY2019Sep 30, 201924M+27.5%
Q2 FY2019Jun 30, 201924M+44.7%
Q1 FY2019Mar 31, 201923M+53.1%
Q4 FY2018Dec 31, 201821M-68.7%
Q3 FY2018Sep 30, 201819M-68.8%
Q2 FY2018Jun 30, 201816M-68.7%
Q1 FY2018Mar 31, 201815M-62.9%
Q4 FY2017Dec 31, 201767M+165446.5%
Q3 FY2017Sep 30, 201760M+54.4%
Q2 FY2017Jun 30, 201753M–
Q1 FY2017Mar 31, 201741M–
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 201639M–

More CorMedix figures

See a number that looks wrong?